Astrana Health (NASDAQ:ASTH) Beats Q3 Sales Expectations

3 weeks ago 14

Petr Huřťák

Thu, November 6, 2025 astatine 4:59 PM CST 5 min read

Healthcare services institution Astrana Health reported Q3 CY2025 results beating Wall Street’s gross expectations , with income up 99.7% twelvemonth connected twelvemonth to $956 million. On the different hand, the company’s full-year gross guidance of $3.14 cardinal astatine the midpoint came successful 2.2% beneath analysts’ estimates. Its GAAP nett of $0.01 per stock was 97.6% beneath analysts’ statement estimates.

Is present the clip to bargain Astrana Health? Find retired successful our afloat probe report.

Closes Prospect Health acquisition
Revenue: $956 cardinal vs expert estimates of $950.2 cardinal (99.7% year-on-year growth, 0.6% beat)
EPS (GAAP): $0.01 vs expert expectations of $0.43 (97.6% miss)
Adjusted EBITDA: $68.48 cardinal vs expert estimates of $67.29 cardinal (7.2% margin, 1.8% beat)
The institution dropped its gross guidance for the afloat year to $3.14 cardinal astatine the midpoint from $3.2 billion, a 1.9% decrease
EBITDA guidance for the afloat year is $205 cardinal astatine the midpoint, beneath expert estimates of $220 million
Operating Margin: 2%, down from 5.9% successful the aforesaid 4th past year
Free Cash Flow Margin: 0.8%, down from 6.6% successful the aforesaid 4th past year
Market Capitalization: $1.66 billion

"Astrana delivered coagulated 3rd 4th results and demonstrated beardown momentum successful our archetypal 4th of combined operations with Prospect Health," said Brandon Sim, President and Chief Executive Officer.

Formerly known arsenic Apollo Medical Holdings until aboriginal 2024, Astrana Health (NASDAQ:ASTH) operates a technology-powered healthcare level that enables physicians to present coordinated attraction portion successfully participating successful value-based outgo models.

A company’s semipermanent income show tin bespeak its wide quality. Even a atrocious concern tin radiance for 1 oregon 2 quarters, but a top-tier 1 grows for years. Luckily, Astrana Health’s income grew astatine an unthinkable 33.3% compounded yearly maturation complaint implicit the past 5 years. Its maturation bushed the mean healthcare institution and shows its offerings resonate with customers, a adjuvant starting constituent for our analysis.

Long-term maturation is the astir important, but wrong healthcare, a half-decade humanities presumption whitethorn miss caller innovations oregon request cycles. Astrana Health’s annualized gross maturation of 47.7% implicit the past 2 years is supra its five-year trend, suggesting its request was beardown and precocious accelerated.

Astrana Health Year-On-Year Revenue Growth

This quarter, Astrana Health reported magnificent year-on-year gross maturation of 99.7%, and its $956 cardinal of gross bushed Wall Street’s estimates by 0.6%.